Results 1 to 10 of about 29,610 (149)
The therapeutic use of thrombolytic agents is the natural result of the increasing understanding of the pathophysiologic mechanisms underlying normal and deranged thrombosis and fibrinolysis. Plasminogen activators capable of increasing the production of plasmin exhibit considerable efficacy in the treatment of a variety of arterial and venous ...
openaire +2 more sources
One of the most exciting areas in modern therapeutics relates to the development of clot-dissolving agents for the treatment of acute thromboembolic episodes. Such an objective seems entirely feasible, since fibrin, the major insoluble constituent of the clot, is susceptible to enzymatic lysis, and agents capable of effecting such enzymatic lysis may ...
openaire +4 more sources
A, Bailey, J C, Lydon, F J, Spielman
openaire +2 more sources
Critical Care After Thrombolytic Therapy in Acute Stroke: Who Really Needs the ICU? [PDF]
Moore KG +6 more
europepmc +1 more source
Thrombolytic Therapy After Return of Spontaneous Circulation in Patients With STEMI From Medically Underdeveloped Areas: A Case Series. [PDF]
Lai J +5 more
europepmc +1 more source
Analysis of risk factors for vascular dementia following thrombolytic therapy in patients with acute ischemic stroke. [PDF]
Wang J.
europepmc +1 more source
Thrombolytic Therapy for Massive Pulmonary Embolism in an Antiphospholipid Syndrome Patient With Severe Thrombocytopenia: A Case Report. [PDF]
Ahmadzadeh A +5 more
europepmc +1 more source

